SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-09-000055
Filing Date
2009-05-15
Accepted
2009-05-15 15:14:53
Documents
2
Period of Report
2009-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR 8K FINANCIAL RESULTS 1Q 09 dor8kpr1q09.htm 8-K 22872
2 PRESS RELEASE 1Q 09 pressrelease1q09.htm EX-99.1 20626
  Complete submission text file 0000812796-09-000055.txt   45222
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 09832337
SIC: 2834 Pharmaceutical Preparations